Genzyme Hit With $50M Judgment In Fabry Treatment IP Fight
A Delaware jury found Tuesday that Genzyme Corp. had induced infringement of a Shelbyzyme LLC patent covering a method of treating a rare genetic disease, awarding Shelbyzyme $50 million in damages....To view the full article, register now.
Already a subscriber? Click here to view full article